HDAC6 is a tubulin deacetylase involved in many cellular functions related to cytoskeleton dynamics including cell migration or autophagy. In addition, HDAC6 
Introduction
Cytotoxic T Lymphocytes (CTLs) are a specialized population of CD8 + T cells that provides defense against virus-infected cells and tumors. Naïve CD8 + T cells differentiate into CTLs upon antigen recognition, a process involving the synthesis and storage of cytotoxic mediators into lysosomal-derived lytic granules (LG) (Williams and Bevan, 2007) . CTLs eliminate target cells by different mechanisms, including secretion of pro-inflammatory cytokines, e.g. TNFα or IFNγ (de Saint Basile et al., 2010) , FAS-L ligation to its receptor as well as granule-mediated apoptosis upon cellcell contact and immune synapse (IS) formation (Ritter et al., 2013) .
LG fuse with the plasma membrane and release granzymes, cathepsins and perforins (prf) (Lopez et al., 2013; Pardo et al., 2009 ). The IS acts as a focal point for exocytosis of LG.
LG polarization towards the target cell depends on TCR engagement, driven by the relocation of the centrosome to IS. The LG degranulate at a secretory domain adjacent to the TCR-enriched region within the IS (de Saint Basile et al., 2010; Ritter et al., 2013 ).
Histone deacetylase 6 (HDAC6) is an ubiquitous, cytosolic protein from the class II
HDACs family with X-linked inheritance, that binds to and deacetylates α-tubulin at lys40 (Hubbert et al., 2002; Valenzuela-Fernandez et al., 2008) . HDAC6 also modulates other substrates, e.g. cortactin or hsp90. HDAC6 controls cell migration (Zhang et al., 2007) , T-regulatory functions (de Zoeten et al., 2011) or CD4 + T cell activation (Serrador et al., 2004) . Consistently, HDACs inhibitors impair some immune functions (Mosley et al., 2006; Tsuji et al., 2015) . However, the precise contribution in vivo, by using hdac6 -/-mice, and the mechanisms involved remain unsolved. HDAC6 also functions as a scaffold protein in T cell migration (Cabrero et al., 2006) and the transport of misfolded proteins (Kawaguchi et al., 2003) . In this report, we describe the impaired killing capacity of hdac6 -/-CTLs. The molecular mechanism underlying this defect involves a scaffold role that positions HDAC6 as a protein that oversees the proper movement of LG, their transport to the IS and secretion towards the target cell.
Results and Discussion
HDAC6 deficiency reduces the cytolytic capacity of CD8 + T lymphocytes. We examined the ability of cytotoxic T cells from hdac6 -/-mice to kill target cells in vitro.
CD8
+ T cells from wild-type (WT) and hdac6 -/-mice expressing the transgenic OVAspecific TCR (OT-I) were in vitro activated and cultured to generate CTLs. Cell cytotoxicity was subsequently analyzed by survival of dye-labeled EL4 target cells pulsed or not with OVA257-264 peptide (SIINFEKL). hdac6 -/-CTLs showed decreased killing activity (Fig. 1A) , consistent with reduced expression of CD107a (lamp1) in hdac6 -/-CTLs upon degranulation (Fig. 1B) . Likewise, CTLs from OT-I mice treated with the HDAC6 inhibitor tubastatin A displayed a reduced killing ability (Suppl. Fig.   1A ). We also detected decreased Prf1 secretion from activated (α-CD3+α-CD28 mAbs)
hdac6 -/-CTLs (Fig. 1C, left) . Next, we assessed the secretion promoted by phorbol-12-myristate-13-acetate (PMA), to bypass TCR stimulation. Both CathepsinD and Prf1 decreased in supernatants from activated hdac6 -/-CTLs (Fig. 1C, right) . Altogether, our data demonstrate that hdac6 -/-CTLs show reduced cytotoxic activity, and suggest that HDAC6 controls exocytosis.
We next tested IFN- production; the frequency of CTLs producing IFN and its secretion was unaffected in activated hdac6 -/-CTLs ( Fig. 1D-E) , in contrast to what is described for ACY-1215, a recently described HDAC6 inhibitor, 10-fold more selective than for HDAC1/2/3 (class I HDACs) that shows slight activity against HDAC8 (Tsuji et al., 2015) . Likewise, treatment of CTLs from OT-I mice with tubastatin A had no significant effect (Suppl. Fig. 1B ). Importantly, T-cell signaling induced by anti-CD3-/anti-CD28 mAbs in hdac6 -/-was comparable to control, as determined by PLC1 and erk1/2 phosphorylation (Fig. 1F) . Likewise, the increase in intracellular calcium remained unchanged (Fig. 1G ). As expected, tubulin acetylation at Lys40 was increased in hdac6 -/-CTLs (Fig. 1F) . These results suggest that the killing defect observed does not result from a general impairment of CTLs function. Interestingly, cathepsinD and lamp1 (CD107a) intracellular co-localization was affected in hdac6 -/-CTLs conjugated with target cells, pointing to the mislocalization of lytic mediators in these cells ( Fig. 3A ; images and middle graphs). The decreased secretion of lytic proteins from hdac6 -/-CTLs suggested that HDAC6 regulates exocytosis of LG (Fig. 1C) . Indeed, the translocation of centrosome to the contact area with the target cell was even more pronounced in hdac6 -/-CTLs (Fig. 3A , right graph), in accordance with the effect described with the HDAC inhibitor Trichostatin A on the centrosomal polarization in CD4 + T cells (Serrador et al., 2004) . This suggests that the defective exocytosis may rely on the movement of LG themselves.
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We thus monitored the dynamics of LG at the IS-subcortical cytoskeleton and their release by Total Internal Reflection Fluorescence microscopy (TIRFm). CTLs were loaded with a pH-dependent, lysosomal tracker that allows the visualization of the LG and settled on a stimulating surface to form an IS-like structure (Fig. 3B) . These experiments revealed significant changes in the distribution of the LG and their dynamics, with a marked decrease in the number of LG detected at the IS-like in hdac6
, suggesting alterations to the active transport of the granules from the centrosomal region to the plasma membrane. Indeed, the mean fluorescence intensity detected for hdac6 -/-granules was lowered, which suggest a higher pH and therefore a different degree of maturation, although the LG displayed similar sizes in WT and hdac6 -/- (Fig.   3C ). The most remarkable difference pertained to the xy distribution of the LG, which was wider (diffusion surface) in the hdac6 -/-CTLs, showing enlarged diffusion coefficient though maintaining similar duration times and path lengths (Fig. 3D ). These data suggest that the LG from hdac6 -/-CTLs are not properly targeted and/or that they dock deficiently at the IS.
Tubulin motors control the delivery of LG to the plasma membrane. Whereas dynein controls LG targeting to the centrosome (Burkhardt et al., 1993; Mentlik et al., 2010) , kinesin-1/Slp3/Rab27a complex directs terminal transport to the plasma membrane for exocytosis (Kurowska et al., 2012) . Dynactin may also be part of this complex, linking the cargo to kinesin-1 motor (Haghnia et al., 2007; Hendricks et al., 2010) . We then hypothesized that HDAC6 regulates the movement and delivery of the LG at the IS through kinesin-1. Using a biochemical approach, we observed that HDAC6 formed a complex with kinesin-1 light chain (KLC1) upon triggering with anti-CD3/anti-CD28 mAbs (Fig. 3E) . Moreover, interaction of the kinesin-activator complex dynactin subunits p150-glued and p50-dynamitin was impaired in hdac6 -/- (Fig. 3F) .
In summary, our data support a specific role for HDAC6 in the intracellular localization of lytic mediators and, particularly, in their exocytosis. Therefore, the catalytic and scaffold activities of HDAC6 may act at multiple levels in the control of cytotoxicrelated pathways, making HDAC6 a potential candidate to target CTLs in specific diseases.

Materials and Methods
Mice. hdac6 -/-mice were generated through targeting of exons 10 to 13 (Gao et al., 2007 
Measurement of intracellular variations in Calcium ions by flow cytometry.
The method used for intracellular calcium influx is described (June and Moore, 2004) . In particular, 5x10 6 purified CD8 + CTLs generated in vitro were loaded with 2 µg.ml LG mechanical properties were determined with a user-customized routine developed in
Python. The software can be freely downloaded from:
https://dl.dropboxusercontent.com/u/4050954/VesiclesAnalyser.zip. For more information, see the tutorial included.
Vaccinia virus (VACV) infection and virus titration.
Tails were scarified with VACV (2x10 6 PFU/mouse) by gently scratching (x25) with a 28 1/2 G needle. For virus titration, tails were mechanical disaggregated (1ml of PBS), subjected to freeze-thaw cycles and sonication. Serial dilutions of the homogenates were added to monolayers of CV-1 cells seeded in 24 well plates. Cells were stained with Cristal violet 24 h later. We observed a detection limit of 5 PFU/tail, the number of plaques was multiplied by the reciprocal of sample dilution and converted to p.f.u./g of tissue.
In vitro and in vivo cytotoxicity assay. injection of bone marrow dendritic cells pulsed with 1 µM of SIINFEKL and LPS (1 µgml -1 ) for 1 h. After 7 days, CD45.1 splenocytes were prepared as targets as described above and injected i.p. into recipients. Cells were recovered 24 h later by peritoneal lavage and in vivo killing measured (Hermans et al., 2004; Iborra et al., 2012; Sancho et al., 2008; Schulz et al., 2005) .
Statistical analysis. Data were tested with GraphPad Prism software (La Jolla, California, US) for normality (D'Agostino-Pearson or the Kolmogorov-Smirnov test for small smaples). Student's t or Mann-Whitney test were used for normal or non-normal data, respectively and two-tailed ANOVA for grouped data (Bonferroni posttest). 
